1-[10-[3-(4-Methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one

CAS : 653-03-2

Ref. 3D-AAA65303

Informations sur le produit

• Nom: 1-[10-[3-(4-Methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one
• Synonymes: 1- 10-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazin-2-yl -1-butanone, 1-(10-(3-(4-Methyl-1-piperazinyl)-propyl)-10H-phenothiazin-2-yl)-1-butanone, 1-Butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazin-2-yl)-, 1-Butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazin-2-yl)-, 2-Butyryl-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine, 3-n-Butyryl-10-(3'-N-methyl-piperazino-N'-propyl)phenothiazin, Ahr 3000, Ahr 712, Bayer 1362, Butaperazina, Butaperazina [INN-Spanish], Butaperazine [USAN:INN], Butaperazinum, Butaperazinum [INN-Latin], Butyrylperazine, Butyrylyperazine, Emerex, Hsdb 3297, Megalectil, N-(gamma-(4'-Methyl-1'-piperazinyl)propyl)-3-butyrylphenothiazine, Perazine, (1-oxobutyl)-, Perazine, butyryl-, Randolectil, Repoise, Riker 595, Tyrylen, Unii-Txp4T9106S

Description

1-[10-[3-(4-Methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one is a drug that belongs to the class of first generation antipsychotics. It is a dopamine D2 receptor antagonist and has been used in the treatment of schizophrenia. This drug can induce liver enzymes, which may lead to an increase in levels of drugs such as warfarin, phenytoin, or carbamazepine. The effective dose for this agent is between 40 and 180mg/day. 1-[10-[3-(4-Methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one is metabolized by the liver and excreted through the urine. This drug also interacts with other drugs by inhibiting their metabolism through inhibition of cytochrome P450 enzymes, which are involved in the metabolism of many

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 409.6 g/mol
• Formule: C₂₄H₃₁N₃OS
• Degré de pureté: Min. 95%